Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
It is difficult for patients to clearly understand the risks and benefits of the drugs they are prescribed despite this being a first step toward informed decisions and shared decision-making with health care professionals.1 In this article, the problems and potential of pharmacy leaflets as a nearly ubiquitous but often overlooked means of communicating drug information to patients are discussed.
Hung A, Sieluk J, Doshi P. The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks. JAMA Intern Med. 2016;176(1):11–12. doi:10.1001/jamainternmed.2015.6656
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: